Press Release Archive

06.01.2009

Pfizer Introduces New Treatment And Support Plan For Patients With Overactive Bladder

06.01.2009

Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in Advanced Breast Cancer

05.30.2009

Pfizer Data Identify Certain Lung Cancer Patients Who May Benefit from Treatment with Figitumumab

05.29.2009

Pfizer Presents Data With Novel Investigational Agents In Select Patient Groups With Non-Small Cell Lung Cancer

05.29.2009

New Pfizer Data Helps to Identify Kidney Cancer Patients Who May Be Most Likely to Benefit from Treatment

05.29.2009

Pfizer Invites Public to View and Listen to Webcast of June 12 Conference Call with Analysts at EULAR

05.27.2009

Pfizer’s Sutent is Recommended for Reimbursement for Gastrointestinal Stromal Tumor Patients by British Health Agency

05.19.2009

Pfizer Expands Its Generics Portfolio Through Innovative Licensing Deals, Increasing Access To Medicines For Billions Worldwide

05.19.2009

Addition of Lyrica Significantly Improved Generalized Anxiety Disorder Symptoms in Patients Who Responded Only Partially to Previous GAD Treatments

05.19.2009

EU Commission Approves Pfizer Animal Health’s Vaccine Against Boar Taint

05.13.2009

Pfizer Launches Free Medicines Program For Newly Unemployed Americans

05.13.2009

Pfizer to Present New Clinical Data Highlighting Customized Treatment Approaches For Difficult-To-Treat Cancers

05.12.2009

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

05.12.2009

Greg Simon, Noted Leader In Health And Science Policy, Joins Pfizer

05.05.2009

Pfizer And Wisconsin Alumni Research Foundation (WARF) Sign License Agreement For Human Embryonic Stem Cells

05.04.2009

Dr. Freda Lewis-Hall Joins Pfizer As Chief Medical Officer

04.29.2009

Lyrica Significantly Reduced Pain and Improved Other Symptoms of Post-Traumatic Peripheral Nerve Pain, New Data Show

04.29.2009

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

04.27.2009

Pfizer Reports First-Quarter 2009 Results; Reaffirms Full-Year 2009 Financial Guidance for Revenues and Adjusted Results(1)

04.23.2009

Pfizer Supports The Global Fight Against Malaria And Commemorates World Malaria Day – “Counting Malaria Out”

04.23.2009

Pfizer And University College London Announce Collaboration To Advance Development Of Stem Cell-Based Therapies

04.23.2009

Pfizer Hosts Annual Meeting Of Shareholders; Declares A 16-Cent Second-Quarter 2009 Dividend

04.22.2009

Pfizer and Medicines for Malaria Venture Advancing International Research Efforts in the Fight against Malaria

04.22.2009

New Findings from Global Survey of Women Living with Metastatic Breast Cancer Highlight Strategies to Improve Patient Enrollment in Clinical Trials

04.20.2009

Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders

04.12.2009

Pfizer To Make A Tender Offer To Increase Stake In Pfizer Limited

04.10.2009

Pfizer’s Oncology Business Unit Appoints Vice President of Medical Affairs

04.06.2009

Pfizer Announces Operating Structure and Select Senior Leadership Posts to Be Effective Immediately Upon Close of Wyeth Acquisition

04.03.2009

Pfizer Receives Request for Additional Information from FTC Regarding Proposed Acquisition of Wyeth

04.03.2009

Pfizer Becomes The First Pharmaceutical Company To Be Accredited For Protection Of Human Rights In Clinical Research

04.02.2009

Pfizer Development Pipeline Shows Advances In High-Priority Disease Areas

04.01.2009

Pfizer Discontinues One Sunitinib Phase 3 Trial in Advanced Breast Cancer; Other Advanced Breast Cancer Trials Continue

03.30.2009

Significantly More Patients With Cardiovascular Disease Quit Smoking Using Chantix/Champix(®) (Varenicline) Compared With Placebo

03.30.2009

Intensive Lipitor Therapy Provided Sustained Risk Reduction Of Cardiovascular Events In Older Patients With Heart Disease

03.24.2009

Pfizer Announces Completion of $13.5 Billion Debt Offering

03.22.2009

Pfizer’s Oncology Business Unit Appoints Senior Executive to Head U.S. Region

03.19.2009

Pfizer, PlaNet Finance Partner to Study Options for Expanding Access to Healthcare in China

03.18.2009

Pfizer-Sponsored Prescription Savings Program - Together Rx Access® - Expands Eligibility Criteria in Response to Challenging Economic Times

03.16.2009

U.S. Patent & Trademark Office Grants Reissue Patent Relating to Lipitor

03.12.2009

Wide-Reaching Global Survey Reveals Majority of Women Living with Metastatic Breast Cancer Desire Increased Public Attention

03.09.2009

Pfizer Invites Public to View and Listen to Webcast of Investor Breakfast at Healthcare Conference

03.02.2009

Pfizer and Bausch & Lomb to Co-Promote Products for the Treatment of Ophthalmic Conditions

03.02.2009

Pfizer Expands Portfolio of Generic Medicines in the U.S. and Europe Through Licensing Agreements with Aurobindo

02.23.2009

Pfizer Discontinues Development of Two Phase 3 Compounds

02.09.2009

Pfizer to Publicly Disclose Payments to U.S. Physicians, Healthcare Professionals and Clinical Investigators

02.04.2009

Pfizer and The Pfizer Foundation Recognize "World Cancer Day" Award $7 Million in Grants to Support Global Cancer Control Efforts

02.03.2009

Pfizer’s Sutent is Recommended as First-Line Treatment for Kidney Cancer Patients by British Health Agency

02.01.2009

Lipitor Significantly Reduced hsCRP Levels in Patients with Stable Coronary Artery Disease, According to New Study